SEC-sourced researchBeta
GOSS
Gossamer Bio, Inc.
Company comparison ↗
Data passport
- CIK
- 0001728117
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Nov 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 0.0000 | Mar 17, 2026 |
| December 2024 | 114,701,000.0000 | Mar 17, 2026 |
| December 2025 | 48,471,000.0000 | Mar 17, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 48,471,000.0000 | -170,370,000.0000 | -171,266,000.0000 | 172,249,000.0000 | 295,009,000.0000 | Mar 17, 2026 |
| December 2024 | 114,701,000.0000 | -56,528,000.0000 | -3,468,000.0000 | 315,292,000.0000 | 285,800,000.0000 | Mar 17, 2026 |
| December 2023 | 0.0000 | -179,817,000.0000 | -159,158,000.0000 | — | — | Mar 17, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $48.47M | December 2025 | Mar 17, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $114.7M | December 2024 | Mar 17, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$170.37M | December 2025 | Mar 17, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$171.27M | December 2025 | Mar 17, 2026 | 10-K |
| Total assetsAssets | $172.25M | December 2025 | Mar 17, 2026 | 10-K |
| Total liabilitiesLiabilities | $295.01M | December 2025 | Mar 17, 2026 | 10-K |
New filings
- S-3GOSS · Gossamer Bio, Inc.Nov 16, 2026 · Other
- SCHEDULE 13G/AGOSS · Gossamer Bio, Inc.Nov 16, 2026 · Other
- 8-KGOSS · Gossamer Bio, Inc.Nov 10, 2026 · Current event
- 10-QGOSS · Gossamer Bio, Inc.Nov 10, 2026 · Periodic
- SCHEDULE 13G/AGOSS · Gossamer Bio, Inc.Nov 6, 2026 · Other
- SCHEDULE 13GGOSS · Gossamer Bio, Inc.Nov 6, 2026 · Other
- SCHEDULE 13D/AGOSS · Gossamer Bio, Inc.Oct 29, 2026 · Other
- 8-KGOSS · Gossamer Bio, Inc.Oct 28, 2026 · Current event
- SCHEDULE 13D/AGOSS · Gossamer Bio, Inc.Oct 8, 2026 · Other
- 8-KGOSS · Gossamer Bio, Inc.Sep 28, 2026 · Current event
- SCHEDULE 13D/AGOSS · Gossamer Bio, Inc.Sep 28, 2026 · Other
- 4GOSS · Gossamer Bio, Inc.Sep 25, 2026 · Other
- 4GOSS · Gossamer Bio, Inc.Sep 25, 2026 · Other
- 4GOSS · Gossamer Bio, Inc.Sep 25, 2026 · Other
- 4GOSS · Gossamer Bio, Inc.Sep 25, 2026 · Other
- 4GOSS · Gossamer Bio, Inc.Sep 25, 2026 · Other
- 4GOSS · Gossamer Bio, Inc.Sep 25, 2026 · Other
- 4GOSS · Gossamer Bio, Inc.Sep 25, 2026 · Other